Leah Frye

Leah Frye is a Distinguished Fellow at Schrödinger. She joined the company in 2001 and co-founded the Drug Discovery Group. She led the group for 18 years and rose to the level of Vice President before returning to a focus on science as a senior drug designer and scientific advisor for the team. Under Leah’s leadership, the Drug Discovery Group worked with collaborators to put numerous compounds into clinical trials resulting in 2 FDA approved drugs to date. Recently, Schrödinger has also developed an internal drug discovery pipeline. Leah has over 35 years of experience in drug discovery with an emphasis on medicinal and computational chemistry resulting in inventorship on 20 US patents plus a number of recent patent applications. Prior to Schrödinger, Leah was a Principal Scientist at Boehringer Ingelheim Pharmaceuticals and before that she was an Associate Professor of Chemistry with tenure at Rensselaer Polytechnic Institute.